NRIX - Nurix releases promising phase 1 data on NX-5948 for chronic lymphocytic leukemia
2024-06-17 15:24:57 ET
More on Nurix Therapeutics
- Nurix Therapeutics Advances Promising Protein Degraders For B-Cell Malignancies
- Nurix Therapeutics files for mixed shelf securities offering
- Seeking Alpha’s Quant Rating on Nurix Therapeutics
- Historical earnings data for Nurix Therapeutics